Autoimmune disorders, rheumatoid arthritis, systemic inflammation, and immune dysregulation
264 articles
A new veterinary sedative is contaminating the illegal fentanyl supply, posing novel overdose risks that standard treatments may not reverse.
A 2026 NEJM commentary examines the alarming resurgence of measles in 2025 and what it means for public health and clinical practice.
New research reveals that mitochondrial energy pathways directly govern dendritic cell immune activation, with major implications for cancer and autoimmune therapies.
A Stanford RCT finds pulsed electromagnetic field therapy significantly reduces thumb CMC osteoarthritis pain at 6 weeks, even after treatment ends.
Mice lacking the PERP apoptosis gene develop faulty thymic immune screening, accumulating self-reactive T-cells that trigger arthritis as they age.
Pyruvate, a core metabolic molecule, suppresses interferon signaling by directly modifying STAT1 — linking metabolism to immune control.
A bibliometric analysis of 7,037 studies reveals gut microbiota, fibroblast-like synoviocytes, and biologic therapy as the emerging frontiers in RA immunology.
A pilot study finds one 30-minute PAPIMI electromagnetic field session significantly reduced pain scores and raised parasympathetic HRV markers in chronic musculoskeletal pain patients.
New review shows precision biomarkers and biologic drugs are transforming how clinicians select and treat children with persistent cow's milk allergy.
New biomarker in joint tissue correlates with inflammation severity and may explain why some patients don't respond to corticosteroids.
Specialized immune cells use antibodies to kill hepatitis B-infected cells, offering new targets for viral cure strategies.
Breakthrough immunotherapy approach demonstrates effectiveness in treating multiple autoimmune conditions simultaneously.
